Trabectedin + PLD
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Trabectedin + PLD, covering 2021-10-29 to 2022-02-24. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of Symptom Benefit Rate of Trabectedin/PLD in Patients With Recurrent Ovarian Cancer [Phase 3]